Ghana: World Hepatitis Day, July 28 (1)
[Ghanaian Times] The burden of hepatitis B infection is highest in the WHO Western Pacific Region and the WHO African Region, where 116 million and 81 million people, respectively, are chronically infected. In 2019, hepatitis B resulted in an estimated 820 000 deaths, mostly from cirrhosis and hepatocellular carcinoma (primary liver cancer). Hepatitis B can be prevented by vaccines that are safe, available and effective. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 28, 2022 Category: African Health Source Type: news

Alcohol-Related Cirrhosis Associated With Higher Risk of Fractures Alcohol-Related Cirrhosis Associated With Higher Risk of Fractures
The higher risk of fractures remained elevated for the first two decades after diagnosis.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 27, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Clinical Prediction Rules for Ruling Out Cirrhosis in NAFLD Clinical Prediction Rules for Ruling Out Cirrhosis in NAFLD
This study shows that the use of new cutoffs for FIB-4 or the NAFLD Fibrosis Score can accurately rule out cirrhosis in patients with NAFLD.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

New Guidelines Focus on NAFLD in Lean People New Guidelines Focus on NAFLD in Lean People
Lean individuals older than 40 with type 2 diabetes should be screened for NAFLD, urge experts who underline the risk for comorbid conditions and cirrhosis.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 26, 2022 Category: Endocrinology Tags: Gastroenterology News Source Type: news

New Update Focuses on NAFLD in Lean People New Update Focuses on NAFLD in Lean People
Lean individuals older than 40 with type 2 diabetes should be screened for NAFLD, urge experts who underline the risk for comorbid conditions and cirrhosis.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 26, 2022 Category: Endocrinology Tags: Gastroenterology News Source Type: news

Substance-use simulation impairs driving capability in patients with cirrhosis regardless of hepatic encephalopathy - Acharya C, McGeorge S, Fagan A, Wade JB, Lee H, Luketic V, Sterling RK, Thacker L, Bajaj JS.
Driving is independently affected by cirrhosis and hepatic encephalopathy (HE) and alcohol/substance use, but their concomitant impact is unclear. We aimed to determine the impact of alcohol and other substances on driving-simulator performance in cirrhosi... (Source: SafetyLit)
Source: SafetyLit - July 19, 2022 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.TheElecsys HCVDuo immunoassay enables significantly earlier diagnosis of active HCV infection, making it possible to get patients appropriate care sooner to stop both the disease progression and transmission.Basel, 18 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys ® HCV Duo immunoassay in countries that accept the CE Mark. Elecsys HCV Duo is the first available immunoassay that allows the simultaneous ...
Source: Roche Investor Update - July 18, 2022 Category: Pharmaceuticals Source Type: news

Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.TheElecsys HCVDuo immunoassay enables significantly earlier diagnosis of active HCV infection, making it possible to get patients appropriate care sooner to stop both the disease progression and transmission.Basel, 18 July 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Elecsys ® HCV Duo immunoassay in countries that accept the CE Mark. Elecsys HCV Duo is the first available immunoassay that allows the simultaneous ...
Source: Roche Media News - July 18, 2022 Category: Pharmaceuticals Source Type: news

Liver Cancer Risk Persists After DAA Treatment for HCV Liver Cancer Risk Persists After DAA Treatment for HCV
Patients with cirrhosis and those with high fibrosis-4 scores face the highest risks and should continue to be screened.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 14, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Fatty liver disease symptoms: The sign in your vomit that indicates cirrhosis - see a GP
FATTY liver disease is caused by a build-up of fat in the liver. Although in its early stages it often does not cause any harm, it can lead to serious health problems if it develops. Cirrhosis is one such problem and is the most severe stage of the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - July 13, 2022 Category: Consumer Health News Source Type: news

HCV Eradication in HCC and Decreased Hepatic Functional Reserve HCV Eradication in HCC and Decreased Hepatic Functional Reserve
Does DAA therapy after hepatocellular carcinoma treatment benefit patients with advanced-stage HCC or HCC with decompensated cirrhosis?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 12, 2022 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

High Residual Liver Cancer Risk in HCV-Cured Cirrhosis High Residual Liver Cancer Risk in HCV-Cured Cirrhosis
Patients with cirrhosis cured of hepatitis C have a 410 times greater risk of hepatocellular carcinoma than the general population and need regular screening, researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 11, 2022 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Bulevirtide Reduces Hepatitis D Viral Load Bulevirtide Reduces Hepatitis D Viral Load
Data from an ongoing study in patients with compensated cirrhosis and clinically significant portal hypertension have raised hope for an emerging treatment option in this rare, deadly disease.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 6, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Jaundice, Malaise in Woman With Heroin Habit, Inactive Hepatitis B
(MedPage Today) -- HDV diagnosis portends imminent cirrhosis despite initial resolution of symptoms (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - July 5, 2022 Category: Gastroenterology Source Type: news

HF May Not Be Causal Factor in Hepatorenal Syndrome With AKI HF May Not Be Causal Factor in Hepatorenal Syndrome With AKI
A new study sheds light on the hemodynamic changes that accompany the progression of cirrhosis and suggests that cardiac dysfunction might not be a causal factor in hepatorenal syndrome with AKI.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - July 1, 2022 Category: Radiology Tags: Cardiology News Source Type: news